Zobrazeno 1 - 10
of 6 487
pro vyhledávání: '"59"'
Autor:
Agnieszka Skrobała
Publikováno v:
Letters in Oncology Science. 17:57-63
Celem niniejszej pracy był przegląd i prezentacja metod służących do kontroli ruchomości oddechowej pacjenta podczas radioterapii. Przegląd oparto o wybrane doniesienia oraz problemy badawcze zaprezentowane podczas dorocznego spotkania ASTRO 5
Publikováno v:
Infectious Agents and Cancer, Vol 14, Iss 1, Pp 1-11 (2019)
Infectious Agents and Cancer
Infectious Agents and Cancer
Background Persistent infection with human papillomaviruses (HPVs) has been associated with cervical intraepithelial neoplasia (CIN) and cervical cancer. However, why only a fraction of HPV cases progress to cancer is still unclear. Methods We focuse
Autor:
Miroslawa Matecka-Nowak
Publikováno v:
Letters in Oncology Science. 15:95-101
The aim of this paper is to underline the most important aspects of advanced lung cancer therapy.The described trends and problems were presented during ASTRO 59 Conference in San Diego.
Autor:
Ewa Burchardt, Wojciech Burchardt
Publikováno v:
Letters in Oncology Science. 16:1-7
Rak prostaty jest drugim co do częstości nowotworem u mężczyzn w Polsce i na świecie. Wskaźniki zachorowalności ciągle rosną, dlatego dane szacunkowe mówią, że w najbliższych latach będzie to najczęściej występujący nowotwór u mę
Autor:
Chen Yi, Chen Yulan, Qiu Junming, Lin Youping, Tong Huasheng, Xie Guojin, Chen Bin, Jiang Dongxin, Qiu Jialing
Publikováno v:
International immunopharmacology. 98
Autor:
Takeshi Ota, Masaki Anraku, Sho Ozaki, Wataru Takahashi, Hideomi Yamashita, Masaaki Sato, Yuki Nozawa, Jun Nakajima, Osamu Abe, Kanabu Nawa, Shuri Aoki, Toshikazu Imae, Takahiro Karasaki, Keiichi Nakagawa, Jun-ichi Nitadori
Publikováno v:
Oncology Letters
A standard treatment for patients with early-stage non-small cell lung cancer (NSCLC) who undergo surgery, and subsequently develop local failure or intrathoracic oligo-recurrence, has not yet been established. The present study aimed to assess the f
Autor:
Danni Yu, Ute Hoch, Sara M. Tolaney, Adi Diab, Arika Feils, Arlene O. Siefker-Radtke, KyungMann Kim, Jen Birstler, Paul M. Sondel, Sue Currie, Tuan Nguyen, Amy K. Erbe, Matthew D. Hellmann, Nizar M. Tannir
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A67-A67
BackgroundHigh-dose IL2 therapy has shown clinical benefit in metastatic melanoma and renal cell carcinoma, however only in a select subset of patients. Bempegaldesleukin (BEMPEG), a novel CD122-preferential IL2 pathway agonist, preferentially binds
Autor:
Keisuke Hata, Kazuhito Sasaki, Keiichi Arakawa, Hiroaki Nozawa, Masaya Hiyoshi, Satoshi Okada, Hirofumi Sonoda, Kazushige Kawai, Yasutaka Shuno, Toshiaki Tanaka, Manabu Kaneko, Koji Murono, Takeshi Nishikawa, Shigenobu Emoto, Soichiro Ishihara
Publikováno v:
Anticancer research. 39(3)
Background We aimed to investigate the molecular features of synchronous colorectal cancer (CRC). Materials and methods Out of 1,262 patients with CRC, 130 lesions in 59 patients with synchronous CRC were retrospectively analyzed. Microsatellite, v-K
Autor:
Chen-Nen Chang, Chun Chung Chen, Yin-Cheng Huang, Han Chung Lee, Der-Yan Cho, Kuo-Chen Wei, Wen-Kuang Yang
In our translational research, an immunotherapeutic, ADCTA-G, has been developed to emphasize autologous tumor antigens, DC antigen processing/presentation, enhanced tumor immunogenicity and CTL induction. Two clinical trials, Phase I/II [2003-2005Ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::214d4f1ed06d7697b5e41dee2caca722
https://europepmc.org/articles/PMC6216147/
https://europepmc.org/articles/PMC6216147/
Autor:
Deepak Dinakaran, Sarah Baker, Andrei Ghila, Zhighang Jin, Robert Pearcey, Gino Fallone, Michael Hendzel
Publikováno v:
Radiotherapy and Oncology. 139:S27-S28